ZoBio

Starting with ZoBio's proprietary Target Immobilized NMR Screening (TINS) technology, ZoBio has been utilized in over 80 projects to provide highly validated fragment ligands for a variety of challenging targets. ZoBio is developing industry-leading innovative technologies supporting FBDD, including new NMR methods to rapidly elucidate the structures of target-ligand complexes.